| # | Drug | Count |
|---|---|---|
| 0 | SOMATROPIN | 31 |
| 1 | PREDNISONE | 21 |
| 2 | CYCLOPHOSPHAMIDE | 20 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 20 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 20 |
| 5 | RITUXIMAB | 16 |
| 6 | MYCOPHENOLATE MOFETIL | 15 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 15 |
| 8 | LEVOTHYROXINE SODIUM | 13 |
| 9 | AZATHIOPRINE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOMAPACITAN-BECO | 2 | 0.0110 |
| 1 | DESMOPRESSIN ACETATE | 10 | 0.0026 |
| 2 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 3 | PLERIXAFOR | 1 | 0.0007 |
| 4 | TESTOSTERONE ENANTHATE | 1 | 0.0006 |
| 5 | SARGRAMOSTIM | 1 | 0.0006 |
| 6 | FOLLITROPIN ALFA | 1 | 0.0005 |
| 7 | SOMATROPIN | 31 | 0.0004 |
| 8 | BLEOMYCIN SULFATE | 4 | 0.0004 |
| 9 | IFOSFAMIDE FOR INJECTION | 7 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 41 |
| 1 | Alkylating Drug [EPC] | 27 |
| 2 | Recombinant Human Growth Hormone [EPC] | 17 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 16 |
| 4 | Platinum-based Drug [EPC] | 14 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 13 |
| 6 | Purine Antimetabolite [EPC] | 11 |
| 7 | Topoisomerase Inhibitor [EPC] | 11 |
| 8 | Benzodiazepine [EPC] | 9 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Human Growth Hormone [EPC] | 17 | 0.0008 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 2 | Penem Antibacterial [EPC] | 5 | 0.0001 |
| 3 | Topoisomerase Inhibitor [EPC] | 11 | 0.0001 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Nuclear Export Inhibitor [EPC] | 1 | 0.0001 |
| 6 | Purine Antimetabolite [EPC] | 11 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 27 | 0.0001 |
| 8 | Serotonin Reuptake Inhibitor [EPC] | 6 | 0.0001 |
| 9 | Platinum-based Drug [EPC] | 14 | 0.0001 |